These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8435476)

  • 1. Type IV collagenases in invasive tumors.
    Tryggvason K; Höyhtyä M; Pyke C
    Breast Cancer Res Treat; 1993; 24(3):209-18. PubMed ID: 8435476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
    Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
    Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell invasion, matrix metalloproteinases, and the dogma.
    Furcht LT; Skubitz AP; Fields GB
    Lab Invest; 1994 Jun; 70(6):781-3. PubMed ID: 8015282
    [No Abstract]   [Full Text] [Related]  

  • 4. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
    Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
    Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current data on metalloproteinases, obligatory partners of tumor progression].
    Rémy L
    Pathol Biol (Paris); 1997 Nov; 45(9):759-65. PubMed ID: 9538475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
    Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
    Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of type IV collagenases in human breast cancer.
    Stetler-Stevenson WG; Liotta LA; Brown PD
    Cancer Treat Res; 1992; 61():21-41. PubMed ID: 1360233
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion.
    Noël A; Emonard H; Polette M; Birembaut P; Foidart JM
    Pathol Res Pract; 1994 Oct; 190(9-10):934-41. PubMed ID: 7899143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
    Allan JA; Docherty AJ; Murphy G
    Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression and activity of MMPS and their regulators in ovarian cancer.
    Naylor MS; Stamp GW; Davies BD; Balkwill FR
    Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinase domain structure, cellular invasion and metastasis.
    Cockett MI; Birch ML; Murphy G; Hart IR; Docherty AJ
    Biochem Soc Trans; 1994 Feb; 22(1):55-7. PubMed ID: 8206283
    [No Abstract]   [Full Text] [Related]  

  • 15. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
    Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
    Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
    Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
    Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of matrix metalloproteinases with serine protease inhibitors. New potential roles for matrix metalloproteinase inhibitors.
    Mallya SK; Hall JE; Lee HM; Roemer EJ; Simon SR; Golub LM
    Ann N Y Acad Sci; 1994 Sep; 732():303-14. PubMed ID: 7978799
    [No Abstract]   [Full Text] [Related]  

  • 18. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
    Zeng ZS; Cohen AM; Guillem JG
    Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
    Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.